Brief: Medicus Pharma Announces Collaboration Agreement to Expand Phase 2 Clinical Study in Asia Pacific Region
02/12/2024 12:39
Dec 2 (Reuters) - Medicus Pharma Ltd MDCX.V :
* MEDICUS PHARMA LTD. ANNOUNCES COLLABORATION AGREEMENT TO
EXPAND
PHASE 2 CLINICAL STUDY IN ASIA PACIFIC REGION
* MEDICUS PHARMA LTD - PHASE 2 STUDY UNDERWAY IN 9 U.S.
SITES, 25%
PATIENTS RANDOMIZED
* MEDICUS PHARMA LTD - INTERIM DATA ANALYSIS PLANNED FOR Q1
2025,
FDA SUBMISSION IN Q2 2025
Source text: ID:nGNX13ScJ8
Further company coverage: MDCX.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medicus Pharma
See all newsBrief: Medicus Pharma Provides Update On SKNJCT-003 Phase 2 Clinical Study
Brief: Medicus Pharma Enters Into Standby Equity Purchase Agreement
Brief: Medicus Pharma Announces Collaboration Agreement to Expand Phase 2 Clinical Study in Asia Pacific Region
Brief: FSD Pharma Wins Final Judgment To Confirm Arbitration Award Of $3.06 Mln Plus Interest Entered Against Raza Bokhari
Brief: Medicus Pharma Ltd Files For U.S. IPO - SEC Filing